Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/10682
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tekin, Zahide Ekici | - |
dc.contributor.author | Yener, Gülçin Otar | - |
dc.contributor.author | Yüksel, Selçuk | - |
dc.date.accessioned | 2019-08-16T13:32:23Z | |
dc.date.available | 2019-08-16T13:32:23Z | |
dc.date.issued | 2018 | - |
dc.identifier.issn | 0172-8172 | - |
dc.identifier.uri | https://hdl.handle.net/11499/10682 | - |
dc.identifier.uri | https://doi.org/10.1007/s00296-018-4088-z | - |
dc.description.abstract | An acquired form of angioedema that is clinically similar but scarcer than the hereditary form may be caused, even more rarely, by the presence of an underlying autoimmune disease. We report a previously healthy 16-year-old girl with an acquired angioedema as a rare and initial presentation of systemic lupus erythematosus. The patient had no previous angioedema attack and no family history. She did not have any chronic diseases and did not use any medicine regularly. The patient was diagnosed with systemic lupus erythematosus with the presence of polyarthralgia, angioedema, leucopenia, and positivity of immunologic criteria. Her edema resolved with high-dose methylprednisolone and hydroxychloroquine slowly. In conclusion, new-onset angioedema in adolescent girls should be investigated to evaluate autoimmunity and the possibility of systemic lupus erythematosus. The related literature on acquired angioedema associated with systemic lupus erythematosus is also reviewed. © 2018, Springer-Verlag GmbH Germany, part of Springer Nature. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer Verlag | en_US |
dc.relation.ispartof | Rheumatology International | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Acquired angioedema | en_US |
dc.subject | Autoimmunity | en_US |
dc.subject | C1 esterase inhibitor protein | en_US |
dc.subject | C1 inhibitor | en_US |
dc.subject | Systemic lupus erythematosus | en_US |
dc.subject | antinuclear antibody | en_US |
dc.subject | complement component C1s inhibitor | en_US |
dc.subject | complement component C3 | en_US |
dc.subject | complement component C4 | en_US |
dc.subject | hydroxychloroquine | en_US |
dc.subject | methylprednisolone | en_US |
dc.subject | prednisolone | en_US |
dc.subject | adolescent | en_US |
dc.subject | angioneurotic edema | en_US |
dc.subject | antibody titer | en_US |
dc.subject | arthralgia | en_US |
dc.subject | autoimmunity | en_US |
dc.subject | case report | en_US |
dc.subject | clinical article | en_US |
dc.subject | complement classical pathway | en_US |
dc.subject | disease association | en_US |
dc.subject | drug dose reduction | en_US |
dc.subject | drug megadose | en_US |
dc.subject | female | en_US |
dc.subject | human | en_US |
dc.subject | immunofluorescence test | en_US |
dc.subject | juvenile | en_US |
dc.subject | leukopenia | en_US |
dc.subject | priority journal | en_US |
dc.subject | Review | en_US |
dc.subject | systemic lupus erythematosus | en_US |
dc.subject | treatment duration | en_US |
dc.subject | complication | en_US |
dc.subject | Adolescent | en_US |
dc.subject | Angioedema | en_US |
dc.subject | Complement C1 Inactivator Proteins | en_US |
dc.subject | Female | en_US |
dc.subject | Humans | en_US |
dc.subject | Hydroxychloroquine | en_US |
dc.subject | Lupus Erythematosus, Systemic | en_US |
dc.subject | Methylprednisolone | en_US |
dc.title | Acquired angioedema in juvenile systemic lupus erythematosus: case-based review | en_US |
dc.type | Review | en_US |
dc.identifier.volume | 38 | en_US |
dc.identifier.issue | 8 | en_US |
dc.identifier.startpage | 1577 | |
dc.identifier.startpage | 1577 | en_US |
dc.identifier.endpage | 1584 | en_US |
dc.authorid | 0000-0001-9415-1640 | - |
dc.authorid | 0000-0003-2575-6309 | - |
dc.identifier.doi | 10.1007/s00296-018-4088-z | - |
dc.relation.publicationcategory | Diğer | en_US |
dc.identifier.pmid | 29951963 | en_US |
dc.identifier.scopus | 2-s2.0-85049099902 | en_US |
dc.identifier.wos | WOS:000438624900029 | en_US |
dc.identifier.scopusquality | Q2 | - |
dc.owner | Pamukkale University | - |
item.grantfulltext | none | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Review | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.languageiso639-1 | en | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
7
checked on Nov 16, 2024
WEB OF SCIENCETM
Citations
7
checked on Nov 21, 2024
Page view(s)
80
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.